Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer
Condition(s):Lung CancerLast Updated:July 13, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Lung CancerLast Updated:July 13, 2016Completed
Condition(s):Lung CancerLast Updated:December 7, 2016Completed
Condition(s):Metastatic CancerLast Updated:July 7, 2016Completed
Condition(s):Breast CancerLast Updated:September 19, 2022Recruiting
Condition(s):Lung CancerLast Updated:July 20, 2016Withdrawn
Condition(s):Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm; Metastatic Malignant Neoplasm in the BrainLast Updated:February 22, 2024Active, not recruiting
Condition(s):PCNSLLast Updated:November 8, 2022Recruiting
Condition(s):Malignant MelanomaLast Updated:August 1, 2016Completed
Condition(s):Metastatic Malignant Neoplasm in the Brain; Recurrent Non-Small Cell Lung Carcinoma; Stage IV Non-Small Cell Lung Cancer AJCC v7Last Updated:March 9, 2018Terminated
Condition(s):Non Small Cell Lung Cancer; OligoprogressiveLast Updated:May 4, 2022Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.